A recent UK study comparing patient and eyecare professional (ECP) views about information provided on age-related macular degeneration (AMD) and diabetic macular oedema found a distinct difference between what ECPs think they tell patients and what patients remember.
Published in Eye and conducted by the UK Macular Society and research firm Yellow Insights, the study found 68% of ECPs said they always give patients information about macular disease at the point of diagnosis. However, only 21% said they consistently provide information to patients considered at-risk of developing the condition. In contrast, only 56% of patients said they received a clear diagnosis (including the name of the condition) at the time they were diagnosed, 45% said they received an explanation of what may happen to their vision in the future and just 17% of those surveyed said they recalled receiving information about support services. As many as 63% of patients said they did not know their symptoms were due to macular disease (during the diagnostic process) and 25% did not think those symptoms were important.
Bridging the gap
Sarah Berman, general manager of Macular Degeneration New Zealand (MDNZ) said when patients reach out to the charity, staff often detect a knowledge gap about their condition. It’s difficult to know the reasons behind it though as no formal analysis has been undertaken here, she said. “Most patients who contact MDNZ know whether they have wet or dry AMD but may not know the detail of their disease.”
For example, a patient who recently approached MDNZ had been told by his optometrist he had dry AMD but he did not know it could turn into wet or that he needed to use an Amsler grid to help monitor any changes, said Berman. “As it happened, his AMD did turn into wet and – thanks to his call to our helpline and the Amsler grid we sent him – he was informed and contacted his ECP immediately. It saved his sight.”






